AstraZeneca (AZ, NASDAQ: AZN), a leading UK pharmaceutical company, has announced the appointment of Iskra Reic, Ph.D., as Executive Vice President (EVP), International. Reic will be responsible for overseeing the overall strategy and driving sustainable growth across key regions including China, Asian and Eurasian markets, the Middle East & Africa, Latin America, and Australia & New Zealand. This appointment comes in the wake of Leon Wang, AstraZeneca’s former international chief, being under investigation in China and confirmed as “in detention” since November, following his removal for investigation in October.
Iskra Reic’s Leadership and Experience at AstraZeneca
Iskra Reic brings a wealth of experience to her new role, having held several leadership positions within AstraZeneca since joining the company in 2001. Her previous roles include serving as EVP for Europe & Canada and, since 2021, as EVP, Vaccines & Immune Therapies. Reic has also held senior roles across Central & Eastern Europe, Eurasia, the Middle East, and Africa. She has been a member of AstraZeneca’s Senior Executive Team since 2017, making her well-equipped to lead the company’s international strategy and operations.
Implications for AstraZeneca’s International Strategy
The appointment of Iskra Reic as EVP, International, signals AstraZeneca’s commitment to maintaining strong leadership and continuity in its international operations despite the challenges faced by its former executive. Reic’s appointment is expected to provide stability and ensure the continued pursuit of the company’s strategic goals and growth initiatives in the regions under her purview.-Fineline Info & Tech
